Clinical Trial Update: Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated whether adding enoxaparin (LMWH) to first-line chemotherapy improves survival and symptom control in patients with advanced n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED